4//SEC Filing
Sapir Alex 4
Accession 0001209191-18-046800
CIK 0001685071other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:27 PM ET
Size
6.0 KB
Accession
0001209191-18-046800
Insider Transaction Report
Form 4
Sapir Alex
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2018-08-14$22.83/sh+21,700$495,411→ 21,700 total(indirect: By Trust)
Holdings
- 46,909
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.65 - 23.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]The reportable securities are owned directly by Alexander C. Sapir Revocable Trust (the "Trust"). The Reporting person is the trustee of the Trust.
Documents
Issuer
Dova Pharmaceuticals, Inc.
CIK 0001685071
Entity typeother
Related Parties
1- filerCIK 0001709415
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:27 PM ET
- Size
- 6.0 KB